Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/1995
09/20/1995EP0672144A1 Interleukin-6 receptor antagonists
09/20/1995EP0672143A1 LYMPHOTOXIN-$g(b), LYMPHOTOXIN-$g(b) COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF
09/20/1995EP0672142A1 Multivalent and multispecific binding proteins, their manufacture and use
09/20/1995EP0672141A1 Methods of preparing soluble, oligomeric proteins
09/20/1995EP0672140A1 cDNAs ENCODING HUMAN NMDA-22A RECEPTOR SUBUNIT AND ISOFORMS OF THE HUMAN NMDA-R1 RECEPTOR SUBUNIT, TRANSFECTED CELL LINE EXPRESSING THEM
09/20/1995EP0672139A1 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof
09/20/1995EP0672138A1 Chimeric factor viii
09/20/1995EP0672137A1 Gene therapy by retroviral vector with tumor suppressive gene
09/20/1995EP0672136A1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions
09/20/1995EP0672134A1 Peptides useful for inducing tolerance
09/20/1995EP0672133A1 TNF-$g(a) RIBOZYMES AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-$g(a) RIBOZYMES
09/20/1995EP0672132A1 Receptor internalization signals
09/20/1995EP0672131A1 Interaction trap system for isolating novel proteins
09/20/1995EP0672130A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors
09/20/1995EP0672128A1 Stem cell proliferation factor
09/20/1995EP0672127A1 Use of thiol redox proteins for reducing disulfide bonds
09/20/1995EP0672123A1 Multifunctional surface protein of streptococci
09/20/1995EP0672122A1 Oligonucleotides with rna cleavage activity
09/20/1995EP0672119A1 Retroviral mediated transfer of the human multiple drug resistance gene
09/20/1995EP0672118A1 A novel b-lymphoma cell line and antigen
09/20/1995EP0672068A1 Target binding polypeptide
09/20/1995EP0672067A1 Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof
09/20/1995EP0672064A1 Op-3-induced morphogenesis
09/20/1995EP0672061A1 Receptor for oncostatin m and leukemia inhibitory factor
09/20/1995EP0672060A1 Antigen associated with type i diabetes mellitus
09/20/1995EP0672059A1 CYCLIC COMPOUNDS LINKED BY A HETEROCYCLIC RING USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa
09/20/1995EP0672058A1 Calcium channel blocking polypeptides from heteropoda venatoria
09/20/1995EP0672057A1 Analogs of pth
09/20/1995EP0672055A1 Neuropeptide y antagonists
09/20/1995EP0672054A1 A novel molecule which inhibits neuropeptide tyrosine biological function
09/20/1995EP0672053A1 Treatment of septic shock with conjugated biologically active peptides
09/20/1995EP0672051A1 PURIFICATION OF KRINGLE CONTAINING PROTEINS, AND ESPECIALLY t-PA
09/20/1995EP0672048A1 THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION
09/20/1995EP0671954A1 Interferon gene therapy for the treatment of vascular disorders
09/20/1995EP0671951A1 Humanized antibodies reactive with l-selectin
09/20/1995EP0671950A1 Immunological purging of tumor cells from bone marrow using microspheres and monoclonal antibodies
09/20/1995EP0671949A1 USE OF $g(b)-CELL-TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF TYPE II DIABETES AND ASSOCIATED DISEASES
09/20/1995EP0671947A1 Compositions for eliciting cytotoxic t-lymphocyte responses against viruses
09/20/1995EP0671946A1 Immunoreactive peptides from epstein-barr virus
09/20/1995EP0671945A1 Methods and compositions for the modulation of host immune response to allergens
09/20/1995EP0671944A1 Bovine pancreatic trypsin inhibitor derived inhibitors of factor viia-tissue factor complex
09/20/1995EP0671943A1 Use of enzymes, especially bromelain, in the treatment of diarrhoea
09/20/1995EP0671942A1 Medical use, a medical method and a pharmaceutical preparation
09/20/1995EP0671941A1 Bradykinin antagonists
09/20/1995EP0671940A1 Insulin-like peptide
09/20/1995EP0671939A1 Treatment of dermatological malignancies with biologically active peptides
09/20/1995EP0671938A1 Novel biologically active peptides and uses therefor
09/20/1995EP0671937A1 Pharmaceutical emulsion compositions
09/20/1995EP0671936A1 TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-$g(a) FUNCTION
09/20/1995EP0671935A1 Amino acid conjugates of cyclohexapeptidyl amines
09/20/1995EP0671934A1 Method of treating cell damage or depletion
09/20/1995EP0671933A1 Novel uses of il-10
09/20/1995EP0671932A1 Cytokine applications
09/20/1995EP0671931A1 Hemoregulatory peptides
09/20/1995EP0671930A1 Prophylaxis and treatment of adverse oral conditions with biologically active peptides
09/20/1995EP0671929A1 Compositions
09/20/1995EP0671928A1 Synthesis of n-substituted oligomers
09/20/1995EP0671927A1 Human neutralizing monoclonal antibodies to respiratory syncytial virus
09/20/1995EP0671926A1 Immunomodulatory peptides
09/20/1995EP0671924A1 Digitalis-like compounds
09/20/1995EP0671921A1 Method for crosslinking of haemoglobin and use of such crosslinked haemoglobin
09/20/1995EP0671920A1 An anti-idiotypic antibody and its use in diagnosis and in therapy in hiv-related disease
09/20/1995EP0671910A1 Glaucoma treatment
09/20/1995EP0671909A1 Syndecan stimulation of cellular differentiation
09/20/1995EP0671905A1 Stable protein: phospholipid compositions and methods
09/20/1995EP0671902A1 $i(CLOSTRIDIAL) TOXIN DISEASE THERAPY
09/20/1995EP0671879A1 Prevention of retinal injury and degeneration by specific factors
09/20/1995EP0536343B1 Targeted polymeric conjugates of cyclosporin and method for their preparation
09/20/1995EP0448635B1 Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
09/20/1995EP0326595B1 Peptides and antibodies that inhibit platelet adhesion
09/20/1995CN1108662A Method of producing reconstituted lipoproteins
09/20/1995CN1108574A Compound alumen powder
09/20/1995CN1108540A Medicine good for heart
09/20/1995CN1029784C Method of chain combination
09/19/1995US5451659 Polypeptide, DNA fragment encoding the same, drug composition containing the same and process for producing the same
09/19/1995US5451658 Antagonists of human gamma interferon
09/19/1995US5451572 Human relaxin formulation
09/19/1995US5451571 Administering Z-proprolinal
09/19/1995US5451570 Glycopeptide antibiotic, useful against methicillin resistant S. aureus strains
09/19/1995US5451569 No micelles or liposomes
09/19/1995US5451521 Procoagulant proteins
09/19/1995US5451518 Purified human ceramide-activated protein kinase
09/19/1995US5451506 Oncostatin M and novel compositions having anti-neoplastic activity
09/19/1995US5451412 Biologically active undenatured whey protein concentrate as food supplement
09/19/1995US5451411 Polyacrylic acid, crosslinked alginate
09/19/1995US5451410 Modified amino acids for encapsulating active agents
09/19/1995US5451402 Method for killing yeast and sporular microorganisms with haloperoxidase-containing compositions
09/19/1995US5451399 [ALA IL-8]77 and [SER IL-8]72 as Leukocyte adhesion inhibitors
09/19/1995US5451205 Remove and store portion of blood of patient, administer biocompatible oxygen carrier, return blood after patient has blood loss
09/19/1995CA1337050C Monoclonal antibody selectively binding to novel g-csf derivative
09/19/1995CA1337046C Thrombolytic agent
09/19/1995CA1337038C Device comprising means for protecting and dispensing fluid sensitive medicament
09/17/1995CA2144569A1 Peptides for inhibiting pepsin release
09/14/1995WO1995024650A2 Methods of diagnosing and treating preeclampsia
09/14/1995WO1995024501A1 Compositions for the inhibition of tnf formation and uses thereof
09/14/1995WO1995024495A1 Transgenic production of oligosaccharides and glycoconjugates
09/14/1995WO1995024489A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences
09/14/1995WO1995024486A1 ANTIMICROBIAL PROTEINS FROM ARALIA AND $i(IMPATIENS)
09/14/1995WO1995024485A2 Coordinate in vivo gene expression
09/14/1995WO1995024481A2 Humanized monoclonal antibodies against human interleukin-4
1 ... 2827 2828 2829 2830 2831 2832 2833 2834 2835 2836 2837 2838 2839 2840 2841 2842 2843 2844 2845 2846 2847 ... 3163